| Darren A Rodia, DPT | |
|
163 Pottstown Pike, Chester Springs, PA 19425-9518 | |
| (610) 458-6464 | |
| (610) 458-6465 |
| Full Name | Darren A Rodia |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 163 Pottstown Pike, Chester Springs, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669577441 | NPI | - | NPPES |
| 205420767 | Other | PA | TAX IDENTIFICATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PT017477 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darren A Rodia, DPT 163 Pottstown Pike, Chester Springs, PA 19425-9518 Ph: (610) 458-6464 | Darren A Rodia, DPT 163 Pottstown Pike, Chester Springs, PA 19425-9518 Ph: (610) 458-6464 |
News Archive
President Obama on Wednesday signaled in a letter to top Senate Democrats that he may be open to requiring all Americans to have health insurance coverage as part of health care reform.
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).
A structure called "the microtubule network" is a crucial part of our nervous system. It acts as a transportation system within nerve cells, carrying essential proteins and enabling cell-to-cell communications. But in neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, this network breaks down, hindering motor abilities and cognitive function.
Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts.
› Verified 3 days ago
Eileen Tarnowski, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 163 Pottstown Pike, Chester Springs, PA 19425 Phone: 610-458-6464 |